Published in J Magn Reson Imaging on June 24, 1997
Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol (2008) 4.57
Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging (2009) 2.17
Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol (2008) 1.87
Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics (2007) 1.55
Susceptibility-weighted imaging: clinical angiographic applications. Magn Reson Imaging Clin N Am (2009) 1.40
Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med (2008) 1.28
Clinical applications of susceptibility weighted MR imaging of the brain - a pictorial review. Neuroradiology (2007) 1.26
Magnetite Nanoparticles for Medical MR Imaging. Mater Today (Kidlington) (2011) 1.26
Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke (2009) 1.18
Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage (2013) 1.16
High-resolution venography of the brain using magnetic resonance imaging. MAGMA (1998) 1.13
In Vivo Cellular Imaging for Translational Medical Research. Curr Med Imaging Rev (2009) 1.12
R*(2) mapping in the presence of macroscopic B₀ field variations. Magn Reson Med (2011) 1.06
Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology (2010) 1.03
Positive contrast visualization of nitinol devices using susceptibility gradient mapping. Magn Reson Med (2008) 0.93
MR susceptibility imaging. J Magn Reson (2012) 0.91
Positive contrast with alternating repetition time SSFP (PARTS): a fast imaging technique for SPIO-labeled cells. Magn Reson Med (2010) 0.91
Spin dephasing under nonlinear gradients: implications for imaging and field mapping. Magn Reson Med (2011) 0.85
Susceptibility gradient quantization by MRI signal response mapping (SIRMA) to dephaser. Med Phys (2010) 0.82
Susceptibility-weighted imaging: current status and future directions. NMR Biomed (2016) 0.82
Utilizing different methods for visualizing susceptibility from a single multi-gradient echo dataset. MAGMA (2009) 0.81
Diffuse axonal injury at ultra-high field MRI. PLoS One (2015) 0.80
Venocentric Lesions: An MRI Marker of MS? Front Neurol (2013) 0.79
Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia. Mol Med Rep (2014) 0.78
Discriminating pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors by means of susceptibility-weighted imaging. Eur Radiol (2014) 0.78
Multistage Background Field Removal (MUBAFIRE)-Compensating for B0 Distortions at Ultra-High Field. PLoS One (2015) 0.75
Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis. PLoS One (2015) 0.75
Direct in vitro comparison of six three-dimensional positive contrast methods for susceptibility marker imaging. J Magn Reson Imaging (2012) 0.75
Magnetic susceptibility-induced echo-time shifts: Is there a bias in age-related fMRI studies? J Magn Reson Imaging (2016) 0.75
Tracking and Quantification of Magnetically Labeled Stem Cells using Magnetic Resonance Imaging. Adv Funct Mater (2016) 0.75
Echo-dephased steady state free precession. MAGMA (2009) 0.75
Multimodal MEMPRAGE, FLAIR, and [Formula: see text] Segmentation to Resolve Dura and Vessels from Cortical Gray Matter. Front Neurosci (2017) 0.75
An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med (1992) 8.67
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05
Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol (2009) 4.93
Self-navigated spiral fMRI: interleaved versus single-shot. Magn Reson Med (1998) 4.61
Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med (1994) 4.60
Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology (1997) 4.13
Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol (1998) 3.58
Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T(1), T(2), T*(2), and non-Lorentzian signal behavior. Magn Reson Med (2001) 3.48
Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun (1976) 3.30
Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94
The Department of Health's "two week standard" for bowel cancer: is it working? Gut (2004) 2.88
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82
MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med (2000) 2.55
Training in large bowel cancer surgery: observations from three prospective regional United Kingdom audits. BMJ (1999) 2.44
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
In vivo measurement of blood oxygen saturation using magnetic resonance imaging: a direct validation of the blood oxygen level-dependent concept in functional brain imaging. Hum Brain Mapp (1997) 2.23
Indomethacin and perforated duodenal ulcer. Br Med J (1980) 2.21
Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol (2007) 2.18
The spectrum of beta-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol (1991) 2.12
The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging (1999) 2.11
Marriage and mortality in prostate cancer. J Urol (1996) 1.95
Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging (2000) 1.91
Morphometric changes in the human pulmonary acinus during inflation. J Appl Physiol (1985) (2011) 1.89
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) (2007) 1.89
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. Infect Immun (1979) 1.86
Bascom's operation in the day-surgical management of symptomatic pilonidal sinus. Br J Surg (2000) 1.85
Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol (2004) 1.82
Two subtypes of HIV-1 among injection-drug users in southern China. Lancet (1998) 1.82
Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation (1999) 1.76
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Accurate determination of spin-density and T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. Magn Reson Med (1998) 1.71
High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed (2001) 1.70
Vacuolar H(+)-translocating ATPases from plants: structure, function, and isoforms. J Bioenerg Biomembr (1992) 1.67
Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5T: preliminary results. Magn Reson Med (1993) 1.65
Responses to rare visual target and distractor stimuli using event-related fMRI. J Neurophysiol (2000) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr (2000) 1.57
High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.53
Hydrodynamic structure of bovine serum albumin determined by transient electric birefringence. Biophys J (1975) 1.52
Cleft closure for the treatment of pilonidal sinus disease. Colorectal Dis (2011) 1.52
Pleomorphic adenoma with extensive necrosis: report of two cases. Oral Dis (2004) 1.51
Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res (2008) 1.48
Simple and reliable enzyme-linked immunosorbent assay with monoclonal antibodies for detection of Escherichia coli heat-stable enterotoxins. J Clin Microbiol (1984) 1.48
In vivo measurement of changes in venous blood-oxygenation with high resolution functional MRI at 0.95 tesla by measuring changes in susceptibility and velocity. Magn Reson Med (1998) 1.45
Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr (1999) 1.45
Abnormal connectivity of the visual pathways in human albinos demonstrated by susceptibility-sensitized MRI. Neurology (1994) 1.44
Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology (1999) 1.44
Intraoral approach for arthroplasty for correction of TMJ ankylosis. Int J Oral Maxillofac Surg (2009) 1.43
Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci U S A (1996) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Survival and disease progression in human immunodeficiency virus-infected women after an index delivery. Am J Obstet Gynecol (1992) 1.39
Coronary arteries: three-dimensional MR imaging with retrospective respiratory gating. Radiology (1996) 1.38
Uncoupling of the autonomic and cardiovascular systems in acute brain injury. Am J Physiol (1998) 1.37
Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun (1988) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Magnetic susceptibility induced white matter MR signal frequency shifts--experimental comparison between Lorentzian sphere and generalized Lorentzian approaches. Magn Reson Med (2014) 1.33
Quantitative assessment of lung microstructure in healthy mice using an MR-based 3He lung morphometry technique. J Appl Physiol (1985) (2010) 1.32
Revised amino acid sequence for a heat-stable enterotoxin produced by an Escherichia coli strain (18D) that is pathogenic for humans. Infect Immun (1985) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg (2003) 1.32
Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31
In vivo lung morphometry with hyperpolarized 3He diffusion MRI: theoretical background. J Magn Reson (2007) 1.31
Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus. J Clin Microbiol (1984) 1.31
Citrobacter freundii produces an 18-amino-acid heat-stable enterotoxin identical to the 18-amino-acid Escherichia coli heat-stable enterotoxin (ST Ia). Infect Immun (1989) 1.31
Triosephosphate isomerase: a highly evolved biocatalyst. Cell Mol Life Sci (2010) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Parametrically dissociating speech and nonspeech perception in the brain using fMRI. Brain Lang (2001) 1.27
In vivo regional cerebral blood volume: quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging. Radiology (1996) 1.27
In vitro production of an extracellular protease by Legionella pneumophila. Infect Immun (1981) 1.26
Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol (2007) 1.26
Strobilocercus fasciolaris infection with hepatic sarcoma and gastroenteropathy in a Wistar colony. Vet Parasitol (2006) 1.20
High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology (2001) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS (2001) 1.19
Emergence of an invasive clone of nontoxigenic Corynebacterium diphtheriae in the urban poor population of Vancouver, Canada. J Clin Microbiol (2006) 1.17
Evaluation of Delorme's procedure as a treatment for full-thickness rectal prolapse. Br J Surg (2000) 1.16
Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol (1999) 1.16
Detection of BOLD changes by means of a frequency-sensitive trueFISP technique: preliminary results. NMR Biomed (2001) 1.15
Extracellular apparent diffusion in rat brain. Magn Reson Med (2001) 1.14
Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using a double-echo gradient-echo sequence. Magn Reson Med (1996) 1.14
Effects of permeable boundaries on the diffusion-attenuated MR signal: insights from a one-dimensional model. J Magn Reson (2004) 1.14
Detection of Helicobacter pylori by PCR but not culture in water and biofilm samples from drinking water distribution systems in England. J Appl Microbiol (2004) 1.13
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
High-resolution venography of the brain using magnetic resonance imaging. MAGMA (1998) 1.13
Biological and immunological characteristics of 125I-4Tyr and -18Tyr Escherichia coli heat-stable enterotoxin species purified by high-performance liquid chromatography. Anal Biochem (1985) 1.12
Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. J Magn Reson Imaging (2011) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Improving susceptibility mapping using a threshold-based K-space/image domain iterative reconstruction approach. Magn Reson Med (2012) 1.11
Quantitative differentiation between BOLD models in fMRI. Magn Reson Med (2001) 1.10
Offline testing of the ATHENA Hypertension decision support system knowledge base to improve the accuracy of recommendations. AMIA Annu Symp Proc (2006) 1.10
Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol (2008) 1.09
Intracranial aneurysms: evaluation by MR angiography. AJNR Am J Neuroradiol (1990) 1.08
Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol (1997) 1.08